Abivax S.A. Cash Flow Statement

Cash Flow Statement Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -50.24M-64.02M-158.96M-188.33M
Share-based Compensation 0.98M-1.23M8.80M21.61M
Deferred Taxes 0.06M
Gains from Investment Securities -2.87M-11.40M-1.25M1.51M
Asset Writedowns and Impairment 14.37M
Change in Working Capital 0.79M2.11M-22.88M-1.52M
Change in Receivables -2.34M0.33M-15.31M4.91M
Change in Account Payables 1.35M-2.52M34.17M-3.68M
Cash from Operations -53.31M-56.85M-104.51M-164.64M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.36M0.51M0.76M1.18M
Investing Activities
Capital Expenditures 0.06M0.30M0.29M0.68M
Cash from Investing Activities -7.37M-12.67M-8.71M16.84M
Financing Activities
Other financing activities 0.00M0.18M0.26M
Change in Capital Stock
Shares Issued 82.46M48.73M380.21M
Misc.
Cash from Financing Activities 97.84M33.95M360.75M30.14M
Exchange Rate Effect -5.46M2.55M
Change in Cash 37.16M-35.57M242.08M-115.11M
Beginning Cash Balance 34.68M63.98M29.00M269.22M
Free Cash Flow -53.37M-57.15M-104.79M-165.32M
Net Cash Flow 37.16M-35.57M247.54M-117.66M